Keywords: scios, natrecor, enters, ph, iii, heart, failure

Scios Natrecor Enters Ph III For Heart Failure

Article | 18 November 1996

Print This

Scios has begun Phase III clinical studies of Natrecor (brain natriuretic peptide) for the treatment of acute congestive heart failure. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in